CCVAX Performance — Calvert Small Cap Fund, Class A
Data updated: 2026-08-27
CCVAX returned +9.44% year to date and +4.89% over one year to Jun 2026. Annualised returns are +5.60% over 3 years and +2.55% over 5 years. The fund trailed its US Small Blend category average: $100 invested three years ago grew to $118, against $156 for the category, and to $105 over one year, against $133. Volatility over the past three years was 17.35% a year. In the 12 months to Jun 2026 the fund lost a net $1.0B, and assets reached $1.28B.
CCVAX Growth of $100
What $100 invested in Calvert Small Cap Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Small Blend category average over the same months.
| Period | CCVAX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $105 | $133 |
| 3 years (Jul 2023 – Jun 2026) | $118 | $156 |
| 5 years (Jul 2021 – Jun 2026) | $113 | $141 |
| Since data start (Jul 2019 – Jun 2026) | $151 | $209 |
CCVAX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.44% |
| 1 year | +4.89% |
| 3 years (annualised) | +5.60% |
| 5 years (annualised) | +2.55% |
CCVAX Annual Returns
Calendar-year total returns of Calvert Small Cap Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +9.44% |
| 2025 | −6.39% |
| 2024 | +11.93% |
| 2023 | +11.43% |
| 2022 | −16.11% |
| 2021 | +19.68% |
| 2020 | +14.65% |
| 2019 (Jul–Dec) | +2.95% |
CCVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.8% | +1.3% | −7.5% | +6.6% | −1.9% | +7.6% | — | — | — | — | — | — |
| 2025 | +3.2% | −2.7% | −4.8% | −3.4% | +4.5% | +1.2% | −2.3% | +5.0% | −4.0% | −2.6% | +0.5% | −0.7% |
| 2024 | −2.3% | +5.2% | +4.3% | −6.6% | +3.2% | −1.4% | +6.9% | +1.5% | +1.0% | −2.4% | +10.8% | −7.2% |
| 2023 | +9.4% | 0.0% | −2.7% | −0.5% | −3.9% | +6.7% | +2.6% | −3.5% | −6.9% | −5.9% | +8.4% | +9.2% |
| 2022 | −7.5% | +3.2% | −1.0% | −6.6% | −2.5% | −5.8% | +9.0% | −5.7% | −8.2% | +11.1% | +3.7% | −4.8% |
| 2021 | +0.2% | +6.1% | +3.2% | +3.0% | +0.4% | −0.3% | +0.1% | +1.4% | −3.0% | +4.9% | −4.0% | +6.7% |
| 2020 | −1.1% | −7.8% | −16.5% | +10.3% | +5.2% | +0.6% | +4.6% | +4.1% | −4.5% | +2.9% | +11.6% | +8.3% |
| 2019 | — | — | — | — | — | — | +1.8% | −2.9% | +0.4% | −0.3% | +3.0% | +0.9% |
CCVAX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 17.35%
- 3-year Sharpe ratio: 0.06 (vs 4.5% risk-free rate)
- Best month: +10.75% (Nov 2024)
- Worst month: −7.48% (Mar 2026)
CCVAX Fund Flows
Monthly money in and out of Calvert Small Cap Fund, from SEC Form N-PORT.
- 12-month net flow: −$1.0B
- 12-month gross sales (incl. reinvestments): $926.5M
- Sales ÷ redemptions: 0.47×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $66.4M | $321.9M | −$255.6M |
| May 2026 | $57.5M | $121.8M | −$64.3M |
| Apr 2026 | $53.9M | $141.8M | −$87.9M |
| Mar 2026 | $87.7M | $162.4M | −$74.8M |
| Feb 2026 | $72.0M | $179.9M | −$108.0M |
| Jan 2026 | $138.9M | $283.2M | −$144.2M |
| Dec 2025 | $291.9M | $274.0M | $17.9M |
| Nov 2025 | $25.0M | $152.0M | −$127.0M |
| Oct 2025 | $44.8M | $142.3M | −$97.5M |
| Sep 2025 | $29.1M | $65.4M | −$36.3M |
| Aug 2025 | $27.8M | $65.0M | −$37.2M |
| Jul 2025 | $31.5M | $59.2M | −$27.7M |
CCVAX Assets Under Management
Net assets of Calvert Small Cap Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.28B |
| 2026-03-31 | $1.52B |
| 2025-12-31 | $1.88B |
| 2025-09-30 | $2.37B |
| 2025-06-30 | $2.51B |
| 2025-03-31 | $2.53B |
| 2024-12-31 | $2.76B |
| 2024-09-30 | $2.84B |
| 2024-06-30 | $2.88B |
| 2024-03-31 | $3.18B |
| 2023-12-31 | $3.02B |
| 2023-09-30 | $2.84B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.